These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11155959)

  • 1. Embryo freezing to prevent ovarian hyperstimulation syndrome.
    Queenan JT
    Mol Cell Endocrinol; 2000 Nov; 169(1-2):79-83. PubMed ID: 11155959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S; Blockeel C; Tremellen KP; Fleming R; Tournaye H; Humaidan P; Nelson SM
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevention of ovarian hyperstimulation syndrome.
    Corbett S; Shmorgun D; Claman P; ;
    J Obstet Gynaecol Can; 2014 Nov; 36(11):1024-1033. PubMed ID: 25574681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryo freezing for preventing Ovarian Hyperstimulation Syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (2):CD002806. PubMed ID: 12076453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fresh versus frozen-thawed blastocyst transfer in high responders.
    Kalem Z; Namli Kalem M; Ruso H; Bakirarar B; Gurgan T
    Ginekol Pol; 2018; 89(8):407-413. PubMed ID: 30215458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GnRH agonist trigger and a freeze-all strategy to prevent ovarian hyperstimulation syndrome: a retrospective study of OHSS risk and pregnancy rates.
    Atkinson P; Koch J; Ledger WL
    Aust N Z J Obstet Gynaecol; 2014 Dec; 54(6):581-5. PubMed ID: 25476811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elective frozen-thawed embryo transfer (FET) in women at risk for ovarian hyperstimulation syndrome.
    Zech J; Brandao A; Zech M; Lugger K; Neururer S; Ulmer H; Ruttmann-Ulmer E
    Reprod Biol; 2018 Mar; 18(1):46-52. PubMed ID: 29279182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian hyperstimulation syndrome prevention strategies: cryopreservation of all embryos.
    D'Angelo A
    Semin Reprod Med; 2010 Nov; 28(6):513-8. PubMed ID: 21082511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures.
    Aboulghar MA; Mansour RT
    Hum Reprod Update; 2003; 9(3):275-89. PubMed ID: 12859048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian hyperstimulation syndrome prevention strategies: use of gonadotropin-releasing hormone antagonists.
    Griesinger G
    Semin Reprod Med; 2010 Nov; 28(6):493-9. PubMed ID: 21082508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.
    Humaidan P; Nelson SM; Devroey P; Coddington CC; Schwartz LB; Gordon K; Frattarelli JL; Tarlatzis BC; Fatemi HM; Lutjen P; Stegmann BJ
    Hum Reprod; 2016 Sep; 31(9):1997-2004. PubMed ID: 27343272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we eliminate severe ovarian hyperstimulation syndrome?
    Orvieto R
    Hum Reprod; 2005 Feb; 20(2):320-2. PubMed ID: 15567876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian hyperstimulation syndrome in a frozen-thawed embryo transfer pregnancy: a rare case report.
    Yang L; Wang R; Wang F; Wang F; Zou L
    BMC Pregnancy Childbirth; 2020 May; 20(1):313. PubMed ID: 32434545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?
    Lee C; Tummon I; Martin J; Nisker J; Power S; Tekpetey F
    Hum Reprod; 1998 May; 13(5):1157-8. PubMed ID: 9647538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of thaw embryo transfer after cryopreservation of all embryos in patients at risk of ovarian hyperstimulation syndrome.
    Pattinson HA; Hignett M; Dunphy BC; Fleetham JA
    Fertil Steril; 1994 Dec; 62(6):1192-6. PubMed ID: 7957983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Coasting" (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome.
    D'Angelo A; Amso N
    Cochrane Database Syst Rev; 2002; (3):CD002811. PubMed ID: 12137659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.
    Griesinger G; Verweij PJ; Gates D; Devroey P; Gordon K; Stegmann BJ; Tarlatzis BC
    PLoS One; 2016; 11(3):e0149615. PubMed ID: 26950065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P; Polyzos NP; Alsbjerg B; Erb K; Mikkelsen AL; Elbaek HO; Papanikolaou EG; Andersen CY
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel approach for patients at risk for ovarian hyperstimulation syndrome: elective transfer of a single zona-free blastocyst on day 5.
    Kinget K; Nijs M; Cox AM; Janssen M; Jacobs P; Bosmans E; Ombelet W
    Reprod Biomed Online; 2002; 4(1):51-5. PubMed ID: 12470353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.
    Seyhan A; Ata B; Polat M; Son WY; Yarali H; Dahan MH
    Hum Reprod; 2013 Sep; 28(9):2522-8. PubMed ID: 23633553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.